Central Nervous System Protozoal Infections: Clinical Trials

6 trials for Central Nervous System Protozoal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Central Nervous System Protozoal Infections: new trials by email Literature Review of Central Nervous System Protozoal Infections trials Research Report on Central Nervous System Protozoal Infections

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DON in Pediatric Cerebral Malaria
6-diazo-5-oxo-L-norleucine (DON), Placebo - Malaria, Cerebral
Phase 1 / Phase 2RecruitingDouglas Postels, MD, MS1522022-08-162026-10-23
Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria
LEVETIRACETAM - Seizure, Epilepsy
Phase 1 / Phase 2CompletedUniversity of Rochester72013-01-012016-09-15
Study of the Safety of Intravenous Artesunate
Intravenous Artesunate, Placebo - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command262006-06-122018-10-25
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
Pyrimethamine, Leucovorin calcium, Zidovudine - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)262021-11-04
Study of the Safety of Intravenous Artesunate
Intravenous artesunate - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command402016-10-26
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
Azithromycin, Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedPfizer452008-08-26

Narrower conditions

Malaria, Cerebral (4)  ·  Malaria (3)  ·  Encephalitis (2)  ·  HIV Infections (2)  ·  Toxoplasmosis (2)  ·  Toxoplasmosis, Cerebral (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Epilepsy (1)  ·  Malaria, Falciparum (1)  ·  Seizures (1)

Broader conditions

Central Nervous System Diseases (6)  ·  Central Nervous System Infections (6)  ·  Central Nervous System Parasitic Infections (6)  ·  Infections (6)  ·  Nervous System Diseases (6)  ·  Parasitic Diseases (6)  ·  Protozoan Infections (6)  ·  Mosquito-Borne Diseases (4)  ·  Vector Borne Diseases (4)  ·  Brain Diseases (3)  ·  Abscess (2)  ·  Blood-Borne Infections (2)  ·  Brain Abscess (2)  ·  Coccidiosis (2)

Interventions

Leucovorin (2)  ·  Pyrimethamine (2)  ·  Azithromycin (1)  ·  Diazooxonorleucine (1)  ·  Levetiracetam (1)  ·  Mannitol (1)  ·  Sodium Chloride (1)  ·  Zidovudine (1)

Sponsors

U.S. Army Medical Research and Development Command (2)  ·  Douglas Postels, MD, MS (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Pfizer (1)  ·  University of Rochester (1)

Countries

United States (4)  ·  Malawi (2)

Top investigators

Peter J Weina, MD, PhD (2)  ·  B Luft (1)  ·  Douglas Postels, MD (1)  ·  Gretchen L Birbeck, M.D. (1)  ·  Luft B (1)  ·  Remington J (1)

Results publications

PMID 31672143, PMID 38279124, PMID 41748157

NIH funding

R01NS074409 (1)